Skip to main content
Call
Comparison

QuickIntell vs Infinx: AI Prior Authorization and RCM Automation Compared

Comparisons — illustrative hero for QuickIntell vs Infinx: AI Prior Authorization and RCM Automation Compared

Prior authorization has become one of the most resource-intensive and financially impactful bottlenecks in healthcare operations. The American Medical Asso...

15 min read|Decision|By QuickIntell Team|Last updated:
Medically reviewed by Dr. David Rawaf, MBBS, Imperial College London

Prior authorization has become one of the most resource-intensive and financially impactful bottlenecks in healthcare operations. The American Medical Association reports that physicians spend an average of 14 hours per week on prior authorization activities, while 93% of physicians report care delays due to the authorization process. The financial impact is equally stark: authorization-related denials represent 15-20% of all claim denials, and each failed or incomplete authorization costs the organization both in denied revenue and staff time.

Against this backdrop, two AI-powered platforms have emerged with significant capabilities in authorization automation and broader revenue cycle management: Infinx and QuickIntell. While both leverage artificial intelligence, they approach the problem from different starting points and with different scope.

Infinx specializes in AI-powered prior authorization and patient access, with a focused platform built around eligibility verification, authorization automation, and patient financial clearance. QuickIntell offers a comprehensive AI-native revenue cycle platform where prior authorization (QuickAuth) is one component of a broader system spanning coding, claims, denial management, payment posting, and clinical documentation.

This comparison helps organizations evaluate both platforms — particularly those where prior authorization is a primary pain point but broader revenue cycle optimization is also on the roadmap.

Quick Comparison

FeatureQuickIntellInfinx
Primary FocusFull revenue cycle AI automationPrior authorization and patient access AI
ArchitectureUnified AI platform across all RCMSpecialized AI platform for authorization and eligibility
Prior AuthorizationQuickAuth — prediction, multi-channel automation, approval scoringCore strength — AI-driven authorization automation
Eligibility VerificationMulti-point verification across 3,500+ payersCore strength — real-time eligibility and benefits verification
Medical CodingQuickCode — NLP-powered autonomous codingNot a core capability
Claims ManagementAI-optimized scrubbing and predictive denial scoringNot a core capability
Denial ManagementPredictive prevention + automated appealsLimited to authorization-related denial prevention
Payment PostingQuickERA — AI-automated with underpayment detectionNot a core capability
Patient Financial ClearancePatient financial engagement through QuickVoiceCore strength — cost estimation and financial counseling support
Voice AIQuickVoice — AI voice for payer and patient callsNot a native capability
AI ScribeQuickScribe — clinical documentation AINot a capability
Automation ApproachAI-autonomous with human oversightAI + human-in-the-loop (Infinx staff)
Target MarketPractices, hospitals, health systems, RCM companiesHospitals, health systems, specialty practices

The Prior Authorization Deep Dive

Since prior authorization is where these platforms have the most direct overlap, this section provides a detailed comparison of authorization capabilities.

Infinx Prior Authorization

Infinx has built a focused, deep platform for prior authorization automation. Their approach combines AI technology with trained staff (Infinx refers to this as "AI + experts") to manage the authorization lifecycle:

Requirement determination. Infinx's AI analyzes service orders against payer rules, plan types, and service categories to determine whether prior authorization is required. The system maintains a database of payer authorization requirements that is continuously updated as payers change their rules.

Documentation assembly. Clinical documentation supporting the authorization request is compiled from available encounter data, clinical notes, and relevant diagnostic results. Infinx's staff augment AI-gathered documentation when additional clinical information is needed.

Submission and tracking. Authorization requests are submitted through electronic channels where supported and managed manually (phone, fax) where electronic submission isn't available. Status tracking provides visibility into pending, approved, denied, and expiring authorizations.

Expert follow-up. When authorizations are denied or require peer-to-peer review, Infinx's staff manage the follow-up process, including scheduling peer-to-peer calls and preparing supporting clinical documentation.

Status integration. Authorization status is fed back to the EHR or practice management system, ensuring that scheduling, clinical, and billing staff have visibility into authorization status.

Strengths of Infinx's approach:

  • Deep specialization in authorization workflows
  • Human experts handle complex peer-to-peer and appeal scenarios
  • Strong payer rule database with continuous updates
  • Patient access focus that connects authorization to scheduling and financial clearance

Limitations:

  • Human-dependent model for complex cases creates scalability constraints
  • Authorization is the platform's strength; broader RCM capabilities are limited
  • Organizations still need separate solutions for coding, claims, denial management, and payment posting
  • Phone-based authorization follow-up still relies on human staff rather than AI voice

QuickIntell QuickAuth

QuickAuth approaches prior authorization as one component of an integrated revenue cycle platform, with capabilities designed to both automate the authorization process and feed authorization intelligence into downstream RCM functions.

Predictive requirement detection. QuickAuth goes beyond rule-based determination to predict authorization requirements using AI that considers not just current payer rules but historical patterns, plan variation, and emerging payer behavior changes. When a payer begins requiring authorization for a service that previously didn't require it, QuickAuth detects the pattern from denial data before the rule is formally published.

Approval probability scoring. Each authorization request is scored for likelihood of approval based on the clinical documentation available, the specific payer's approval patterns for that service and diagnosis combination, and the patient's treatment history. A request with a 92% approval probability is handled differently than one with a 45% probability — the latter is flagged for additional documentation before submission.

Multi-channel automation. QuickAuth submits electronically where supported, uses fax automation for payers requiring fax, and deploys QuickVoice (AI voice agents) for phone-based authorizations. QuickVoice can navigate payer phone systems, provide required information, and manage hold times — addressing the 30-40% of authorizations that still require phone interaction.

Documentation assembly with clinical intelligence. The AI doesn't just compile available documentation — it evaluates whether the assembled documentation meets the specific payer's medical necessity criteria for the requested service and diagnosis. If gaps exist, it identifies what additional clinical information would strengthen the request and alerts the ordering provider or clinical staff.

Closed-loop integration with denial prevention. Authorization data flows directly into QuickIntell's claims optimization engine. If a claim is submitted for a service where authorization was required but not obtained, the system catches it before submission. If an authorization number on file has expired or doesn't match the billed service, the claim is held for correction. This closed loop between authorization and claims prevents the authorization-related denials that represent 15-20% of all denials industry-wide.

Strengths of QuickAuth's approach:

  • Predictive requirement detection catches requirements before they delay care or cause denials
  • Approval probability scoring enables intelligent resource allocation
  • QuickVoice handles phone-based authorizations that other platforms still delegate to staff
  • Integration with the broader RCM platform creates a closed loop between authorization and claims

Limitations:

  • Authorization is one of many platform capabilities, not the sole focus
  • Less human intervention in the workflow (which is a strength for routine cases but may require supplementation for complex peer-to-peer scenarios)

Head-to-Head Authorization Comparison

Authorization CapabilityQuickIntell QuickAuthInfinx
Requirement determinationAI-predictive (detects emerging requirements)AI + rules database
Approval probability scoringYes — per-request scoringLimited
Electronic submissionYesYes
Phone-based automationQuickVoice AIHuman staff
Fax automationYesYes
Peer-to-peer schedulingAI-assistedHuman expert-managed
Documentation gap analysisAI-evaluated against payer criteriaHuman review
Status trackingAutomated with intelligent follow-up timingAutomated with manual follow-up
Integration with claimsDirect — prevents authorization-related denialsIndirect — status data shared with billing
Expiration managementProactive alerts with re-authorization initiationStatus tracking with alerts

Beyond Prior Authorization: The Broader RCM Comparison

For organizations where prior authorization is the primary pain point, the comparison above may be sufficient. But most organizations face revenue cycle challenges that extend well beyond authorization. Here's where the platforms diverge most significantly.

Capabilities QuickIntell Provides That Infinx Does Not

AI Medical Coding (QuickCode). NLP-powered coding that reads clinical documentation and suggests complete code sets with confidence scoring. For organizations with coder shortages, coding backlogs, or coding accuracy concerns, this capability addresses a problem that Infinx's platform does not touch. Coding accuracy directly impacts denial rates — every miscoded claim is a potential denial that authorization automation cannot prevent.

Claims Optimization. Per-claim predictive denial scoring that evaluates claims across dozens of variables before submission. This goes beyond authorization verification to catch coding errors, eligibility issues, documentation gaps, payer-specific edit violations, and pattern-based denial risks. Infinx's platform does not process or optimize claims.

Comprehensive Denial Management. Prevention-first denial management that predicts denials across all categories — not just authorization-related denials. Automated appeal generation, submission, and tracking for denials that do occur. Infinx's denial prevention is limited to authorization-related denials; QuickIntell prevents denials across all root causes.

Payment Posting with Underpayment Detection (QuickERA). AI-automated payment posting that compares actual payments against expected payments and identifies systematic underpayment patterns. This revenue recovery capability addresses money already earned but not fully collected. Infinx does not participate in payment posting or reconciliation.

AI Voice Communication (QuickVoice). AI voice agents that handle payer calls (authorization, claim status, appeals) and patient calls (billing inquiries, payment arrangements). This capability extends automation into the phone-based workflows that consume significant staff time. Infinx does not offer voice AI.

Clinical Documentation AI (QuickScribe). AI-powered clinical documentation that captures and structures encounter information, supporting both clinical care and downstream coding and billing accuracy. Better documentation leads to better coding, which leads to fewer denials. Infinx does not offer clinical documentation capabilities.

Capabilities Infinx Provides That QuickIntell Approaches Differently

Patient Financial Clearance. Infinx offers patient financial clearance capabilities — estimating patient financial responsibility, identifying coverage gaps, and supporting financial counseling conversations before or at the time of service. QuickIntell addresses patient financial engagement through QuickVoice (AI-powered billing communication and payment arrangement) but does not offer the same depth of pre-service financial clearance workflow.

Dedicated Authorization Expertise. Infinx's human-in-the-loop model provides dedicated authorization specialists who manage complex cases, peer-to-peer reviews, and payer relationships. This human expertise can be valuable for organizations with particularly complex authorization environments (transplant programs, specialty pharmacy, complex surgical procedures). QuickIntell's AI-autonomous model handles most authorization workflows without dedicated human staff but may require the organization to manage complex peer-to-peer scenarios with their own clinical staff.

Evaluating Based on Organizational Needs

If Prior Authorization Is Your Only Pain Point

If your organization's revenue cycle challenges are concentrated in prior authorization — high authorization volumes, staff burnout from phone-based authorizations, authorization-related denials, and care delays — both platforms deserve evaluation.

Choose Infinx if: You want a dedicated authorization platform with human experts managing complex cases, and you have separate solutions for coding, claims, and denial management that are working well.

Choose QuickIntell if: You want authorization automation with predictive intelligence and voice AI, plus the ability to expand into broader RCM automation as needed. QuickAuth can be deployed as an entry point with the full platform available for expansion.

If You Need Broader RCM Automation

If prior authorization is a pain point but so are coding accuracy, denial rates, claims optimization, or payment accuracy, QuickIntell is the more comprehensive choice. Using Infinx for authorization and separate solutions for coding, claims, denial management, and payment posting creates a fragmented technology stack with multiple vendors, multiple integrations, and no cross-function intelligence.

QuickIntell's unified platform means authorization intelligence feeds into claims optimization, coding accuracy reduces authorization-related denials, and denial prevention spans all root causes — not just authorization issues.

The Fragmentation vs. Integration Decision

ApproachInfinx + OthersQuickIntell
Prior authorizationInfinxQuickAuth
Medical codingSeparate vendor neededQuickCode
Claims processingSeparate vendor neededBuilt-in
Denial managementSeparate vendor neededBuilt-in
Payment postingSeparate vendor neededQuickERA
Voice AINot availableQuickVoice
Integration complexityMultiple vendor integrationsSingle platform
Cross-function intelligenceNone — siloed dataFull — every module informs every other
Vendor managementMultiple contracts and relationshipsSingle vendor

Implementation and Integration

Infinx: Implementation typically takes 4-8 weeks for authorization automation, including payer rule configuration, EHR integration, workflow design, and staff training. The human-in-the-loop model requires coordination with Infinx's authorization team. Integration focuses on receiving orders and clinical data from the EHR and returning authorization status.

QuickIntell: Full platform implementation takes 8-12 weeks. For organizations deploying QuickAuth specifically, authorization capabilities can be operational within 4-6 weeks with broader platform modules activated in subsequent phases. Integration includes bidirectional data exchange with the EHR for clinical data, orders, claims, and financial postings.

Pricing

Infinx: Pricing is typically per-transaction (per authorization request) or subscription-based with volume tiers. The human-in-the-loop model means pricing includes a labor component that scales with authorization volume.

QuickIntell: Offers percentage-of-collections and per-claim pricing for the full platform, with module-specific pricing available for organizations deploying specific capabilities. The AI-autonomous model provides lower marginal cost per transaction at scale.

Cost comparison note: Comparing Infinx's authorization-specific pricing to QuickIntell's full-platform pricing is not apples-to-apples. The relevant comparison is the total cost of Infinx plus whatever other solutions the organization uses for coding, claims, denials, and payment posting versus QuickIntell's consolidated platform cost. In most cases, the consolidated approach is more cost-effective.

The Bottom Line

Infinx is a strong, focused platform for organizations whose primary challenge is prior authorization and patient access. Its combination of AI technology and human authorization experts provides reliable, specialized coverage for one of healthcare's most burdensome administrative processes.

QuickIntell is a comprehensive AI-native revenue cycle platform where prior authorization (QuickAuth) is integrated with coding, claims, denial prevention, payment posting, voice AI, and clinical documentation. For organizations facing revenue cycle challenges that extend beyond authorization — which is most organizations — the integrated approach provides broader coverage, cross-function intelligence, and lower total technology cost than assembling specialized point solutions.

The choice depends on whether your authorization challenge exists in isolation or as part of a broader revenue cycle opportunity. If authorization is an island, Infinx serves it well. If authorization is connected to coding, claims, denials, and payments — as it almost always is — QuickIntell's integrated platform addresses the full chain.

Frequently Asked Questions

Is Infinx only for prior authorization?

No, Infinx also offers eligibility verification and patient financial clearance capabilities. However, prior authorization is their primary strength and market differentiator. Their platform does not extend into medical coding, claims processing, denial management (beyond authorization-related denials), or payment posting. Organizations using Infinx typically need separate solutions for these functions.

Can QuickIntell match Infinx's depth in prior authorization?

QuickAuth provides comparable or superior authorization automation in most dimensions — including predictive requirement detection and voice AI for phone-based authorizations that Infinx handles with human staff. Where Infinx may have an edge is in dedicated human expertise for complex authorization scenarios like peer-to-peer reviews and appeals with specific payers. QuickIntell's AI handles most of these scenarios autonomously but may require supplementation from the organization's clinical staff for the most complex cases.

What about organizations that already use Infinx — can they add QuickIntell?

Yes, though there would be redundancy in prior authorization and eligibility verification. The practical approach would be to evaluate whether to maintain Infinx for authorization while deploying QuickIntell for coding, claims, denial management, and payment posting — or to consolidate onto QuickIntell's platform. The consolidation approach eliminates redundancy and enables cross-function intelligence but requires transitioning an established authorization workflow.

How do the platforms compare on authorization turnaround time?

Both platforms significantly reduce authorization turnaround compared to manual processes. Infinx reports turnaround reductions of 50-75% with their AI + expert model. QuickIntell's QuickAuth achieves comparable reductions, with the added advantage of QuickVoice for phone-based authorizations. For payers that still require phone interaction (which represents a significant volume for many specialties), QuickVoice provides an automation channel that eliminates hold times and phone-tag that even Infinx's human experts must navigate.

Which platform is better for specialty practices with high authorization volumes?

It depends on the specialty and the broader revenue cycle context. For specialties where authorization is the dominant operational challenge (radiology, specialty pharmacy, DME), Infinx's focused expertise is strong. For specialties where authorization is one of several challenges alongside complex coding, high denial rates, and payer-specific billing requirements (orthopedics, cardiology, oncology), QuickIntell's integrated platform addresses the full picture. Most specialty practices find that authorization-related denials are one component of their total denial rate, and addressing only authorization leaves significant revenue on the table.

Does Infinx offer AI voice for phone-based authorizations?

Not currently. Infinx uses trained human staff for phone-based authorization interactions. QuickIntell's QuickVoice uses AI voice agents to navigate payer phone systems, provide required information, handle hold times, and complete authorization requests. Given that a significant percentage of authorization interactions still require phone contact, voice AI is a meaningful differentiator for organizations seeking full automation of the authorization workflow.

Ready to Transform Your Revenue Cycle?

See how QuickIntell's AI-powered platform can reduce denials, accelerate payments, and eliminate administrative burden for your organization.

Disclaimer: This content is for informational purposes only and does not constitute medical, legal, or financial advice. Consult qualified professionals for guidance specific to your situation.